Opendata, web and dolomites

CAPSULTEK SIGNED

Unlocking the potential of thermo-sensitive bioactive ingredients through a disruptive encapsulation method

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 CAPSULTEK project word cloud

Explore the words cloud of the CAPSULTEK project. It provides you a very rough idea of what is the project "CAPSULTEK" about.

prone    encapsulation    stated    food    vitamins    benefits    eager    basic    first    business    until    bioactive    vulnerable    lasting    temperature    moment    bioinicia    concentration    extend    massively    oxidation    energy    foresee    industrially    fifth    deploying    besides    pressurized    line    demo    50    industrial    foods    2022    functional    entail    damaging    nutritional    electrospraying    prototype    consumers    room    launched    thermolabile    industry    shelf    companies    encapsulated    40    nanoencapsulation    protect    probiotics    acceptance    assisted    intensive    ingredients    innovative    grow    market    certain    global    stability    experts    claim    reduce    matrix    scalable    profit    ph    life    capsultek    formulation    added    bioavailability    adding    encapsulate    additional    health    industries    volumes    bold    molecule    markets    started    revenue    wise    model    usually    living    portfolio    megatrend    gas    designed    integrity    assuring    commercialization    optimize    readiness    plant    omega    easily    introducing   

Project "CAPSULTEK" data sheet

The following table provides information about the project.

Coordinator
BIOINICIA SL 

Organization address
address: CALLE ALGEPSER 65 PUERTA 3
city: PATERNA
postcode: 46980
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Total cost 985˙062 €
 EC max contribution 689˙543 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-2
 Funding Scheme SME-2
 Starting year 2019
 Duration (year-month-day) from 2019-08-01   to  2021-07-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    BIOINICIA SL ES (PATERNA) coordinator 689˙543.00

Map

 Project objective

Functional foods provide additional health benefits beyond its nutritional value by adding certain bioactive ingredients to its basic formulation, like Omega-3, probiotics or vitamins. They are massively consumed, being a long-lasting megatrend in food industry, started in the 80’s, and currently living its best moment. Their generated revenue will grow by 50 % until 2022. 1 out of 4 new food products launched have a functional claim. So, global food industries are eager to increase their functional food products portfolio due to its high consumers’ acceptance, potential for deploying new markets, and higher added value. However, most of these bioactive ingredients are easily vulnerable (prone to oxidation, thermolabile…), so, there is a challenge in assuring their integrity and bioavailability when introducing them in food products (complex matrix!). To protect them they are usually encapsulated. Most encapsulation methods work at high temperature damaging the ingredients. Moreover, most methods are energy-intensive, and entail high production costs. In Bioinicia we are experts in nanoencapsulation, and we have developed CAPSULTEK: an innovative own-developed technology called Electrospraying Assisted by Pressurized Gas of which we have a 1 t/year prototype. With our technology we can work at room temperature, encapsulate any kind of molecule, enhance its stability and extend its shelf-life. Besides, industrially-wise, we can scale it up to reach industrial volumes, to reduce encapsulation costs by 40% and to increase concentration bioactive ingredients by 50%. We need Ph.2 to reach market readiness. We will build an industrial demo plant of 10 tonnes/year and will optimize the processing parameters for Omega-3 and probiotics. We have designed a bold and effective highly scalable business model to make the most of CAPSULTEK. First-line food companies have already stated their interest on it, and we foresee an 8 M€ profit by the fifth year of its commercialization.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CAPSULTEK" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "CAPSULTEK" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

In-Heal (2019)

Standardised administration device for raw medical herbs

Read More  

MCBD (2019)

MCBD (MULTI-CORE BIOPSY DEVICE) INNOVATIVE BIOPSY TECHNOLOGY FOR THE NEW ERA OF TARGETED MEDICINE

Read More  

SQP (2019)

Opening new markets for Single Quantum Photodetectors

Read More